» Articles » PMID: 12884862

The Efficacy of Complement-mediated Phagocytosis of Cryptococcus Neoformans is Dependent on the Location of C3 in the Polysaccharide Capsule and Involves Both Direct and Indirect C3-mediated Interactions

Overview
Journal Eur J Immunol
Date 2003 Jul 30
PMID 12884862
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Complement component 3 (C3) is the major opsonin for the pathogenic fungus Cryptococcus neoformans in the non-immune host. However, the efficiency of complement-mediated opsonization varies, depending on the strain, through mechanisms that are not understood. Analysis of complement-mediated phagocytosis for 12 strains grown in Sabouraud medium revealed that phagocytic indices were inversely correlated with capsule volume. In contrast, there was no correlation between phagocytic index and capsule volume for IgG1-opsonized cells. When capsule size was increased, the efficacy of complement-mediated phagocytosis decreased, whereas that of antibody-mediated phagocytosis increased. C3 localized inside the capsule and at the outer capsule edge for poorly phagocytozed and well-phagocytozed strains, respectively. Blocking experiments revealed that complement-mediated phagocytosis occurred through complement receptor 3 (CR3), without significant involvement of CR1 or CR4. Blocking experiments with antibodies to C3 did not completely abrogate yeast cell uptake, consistent with phagocytosis through glucuronoxylomannan-CR3 interactions. Our data explain how some large encapsulated cells avoid phagocytosis and suggest a novel strategy for immune evasion whereby a microbial capsule interferes with phagocytosis by modifying the location of C3 deposition.

Citing Articles

Establishment of a predictive model of CT value in the diagnosis and differential diagnosis of pulmonary cryptococcosis.

Ning Y, Meng F, Zhang H, Li W, Ke Z, Xu F Heliyon. 2024; 10(13):e33899.

PMID: 39055788 PMC: 11269869. DOI: 10.1016/j.heliyon.2024.e33899.


Assessing Phagocytosis of Cryptococcus neoformans Cells in Human Monocytes or the J774 Murine Macrophage Cell Line.

Lafont E, Sturny-Leclere A, Coelho C, Lanternier F, Alanio A Methods Mol Biol. 2024; 2775:157-169.

PMID: 38758317 DOI: 10.1007/978-1-0716-3722-7_11.


Proteasome inhibition as a therapeutic target for the fungal pathogen .

Caza M, Santos D, Burden E, Brisland A, Hu G, Kronstad J Microbiol Spectr. 2023; :e0190423.

PMID: 37750732 PMC: 10580939. DOI: 10.1128/spectrum.01904-23.


Antibodies to Combat Fungal Infections: Development Strategies and Progress.

Rabaan A, Alfaraj A, Alshengeti A, Alawfi A, Alwarthan S, Alhajri M Microorganisms. 2023; 11(3).

PMID: 36985244 PMC: 10051215. DOI: 10.3390/microorganisms11030671.


Metagenomic next-generation sequencing assists in the diagnosis of pneumonia: Case series and literature review.

Wang H, Yan S, Liu Y, Li Y, Cui G, Ma X Front Public Health. 2022; 10:971511.

PMID: 36408040 PMC: 9672815. DOI: 10.3389/fpubh.2022.971511.